<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01355341</url>
  </required_header>
  <id_info>
    <org_study_id>ACE/HMP-01</org_study_id>
    <nct_id>NCT01355341</nct_id>
  </id_info>
  <brief_title>Safety and Efficacy of Herbmed Plus in Patients withRenal Calculi</brief_title>
  <acronym>HerbmedPlus</acronym>
  <official_title>A Phase II, 28 Week, Randomized, Double- Blind, Placebo- Controlled, Parallel Group Study to Evaluate the Safety and Efficacy of 'Herbmed Plus' an Ayurvedic Formulation in Patients With Renal Calculi</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Amai Charitable Trust</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Amai Charitable Trust</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      More specifically, the present invention relates to a 'Herbal Preparation' that is useful for

        -  Treatment of Renal calculi

        -  Reduction in the stone size &amp; surface area

        -  The expulsion of stone

        -  Decreased need of Analgesic(Antiinflammatory Effect)

        -  Stops the recurrence and reformation of renal
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      1. Study duration 28 weeks

        2. No. of Scheduled visits 8 visits

        3. Study product Dose, Group one-:1capsule (of 500 mg) orally twice a day with meals for 24
           weeks. Group two-:placebo1capsule (of 500 mg) orally twice a day with meals for 24
           weeks.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>April 2010</start_date>
  <completion_date type="Anticipated">December 2011</completion_date>
  <primary_completion_date type="Anticipated">December 2011</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>To evaluate the efficacy of &quot;Herbmed plus&quot;in patients with urinary calculi by assessing the reduction in the stone size &amp; surface area/ or the expulsion of stone</measure>
    <time_frame>In 210 days</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Reduction in the size of stone Reduction in the density of the stone Painless expulsion of the stone/fragments Reduction in pain Consumption of Analgesics</measure>
    <time_frame>In 210 days</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">84</enrollment>
  <condition>RENAL CALCULI</condition>
  <arm_group>
    <arm_group_label>HERBMED PLUS</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Herbal formulation of four constituents i.e.Varuna,Yav,Aghada,Kadali as per ayurvedic literature.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>HERBMED PLUS</intervention_name>
    <description>500 mg Twice day for 6 month with lunch and dinner.</description>
    <arm_group_label>HERBMED PLUS</arm_group_label>
    <other_name>Herbmed plus is ayurvedic formulation</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 10-75 years (Both inclusive)

          -  Patients with Renal calculi, diagnosis confirmed by plain X-ray KUB &amp;/or ultrasound
             KUB/CT scan Abdomen

          -  Size of the calculi ranging from 04 mm -09 mm

          -  Able and willing to give written informed consent and comply with the requirements of
             the study protocol

          -  Patients of reproductive potential (males and females) and willing to use a reliable
             means of contraception (e.g hormonal contraceptive patch, intrauterine device and
             physical barrier) throughout study participation

          -  Patients will to cooperate &amp; give consent for the trial&amp; comes for regular follow up.

        Exclusion Criteria:

          -  Patients having acute condition of renal calculi.

          -  Any systemic disease requiring other medications of surgery for calculus condition.

          -  Complicated cases of Renal Calculi requiring surgical condition.

          -  Chronic or current infectious disease such as but not limited to chronic renal
             infection including active urinary tract infection.Uncontrolled diabetes,
             hypertension, symptomatic congestive heart failure, unstable angina pectoris,
             myocardial infarction

          -  Any other urogenital disorders.

          -  Liver dysfunction, defined as total bilirubin more then 1.5 the upper limit of Normal,
             aspartate aminotransferase more then 2.5 upper limit of Normal, or alanine
             aminotransferase more then 2.5 upper limit of Normal,

          -  Kidney disease, including serum creatinine level more then 1.5 upper limit of Normal,

          -  Subjects on herbal supplements for stone disease (plant extracts preparations or
             herbal medicines etc.) within previous 3 months.

          -  Participated in another clinical drug trial within 3 months before recruitment.

          -  Pregnancy or breast feeding

          -  Evidence of significant uncontrolled concomitant disease which in the Investigator's
             opinion would preclude patient participation

          -  Currently active alcohol or drug abuse or history of alcohol or drug abuse within 24
             weeks prior to baseline

          -  Patients with psychiatric illness or other condition that would limit compliance with
             study requirements

          -  Patients receiving or has received any investigational drug within 30 days before
             receiving the first dose of study medication

          -  Subjects who refuse to sign the informed consent document .
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>10 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>SURESH B PATANKAR, MS.Mch.</last_name>
    <role>Principal Investigator</role>
    <affiliation>AMAI CHRITABLE TRUST'S ACE HOSPITAL</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>PATANKAR B PATANKAR, MS.MCH</last_name>
    <phone>25434063</phone>
    <phone_ext>100</phone_ext>
    <email>amaitrust@yahoo.co.in; suresh_iou@yahoo.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>SMITA S BHOYAR, BAMS CGO</last_name>
    <phone>25434072</phone>
    <phone_ext>304</phone_ext>
    <email>drsmitabhoyar@rediffmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>AMAI Charitable Trust's ACE Hospital Pune</name>
      <address>
        <city>Pune</city>
        <state>Maharashatra</state>
        <zip>411004</zip>
        <country>India</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>SURESH B PATANKAR, MS.MCH.</last_name>
      <phone>02025434063</phone>
      <phone_ext>100</phone_ext>
      <email>amaitrust@yahoo.co.in</email>
    </contact>
    <contact_backup>
      <last_name>SMITA S BHOYAR, BAMS.CGO</last_name>
      <phone>02025434063,02025434072</phone>
      <phone_ext>304</phone_ext>
      <email>drsmitabhoyar@rediffmail.com</email>
    </contact_backup>
    <investigator>
      <last_name>SURESH B PATANKAR, MS.MCH</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>India</country>
  </location_countries>
  <verification_date>May 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 16, 2011</study_first_submitted>
  <study_first_submitted_qc>May 17, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 18, 2011</study_first_posted>
  <last_update_submitted>May 17, 2011</last_update_submitted>
  <last_update_submitted_qc>May 17, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 18, 2011</last_update_posted>
  <responsible_party>
    <name_title>AMAI CHARITABLE TRUST'S ACE HOSPITAL PUNE</name_title>
    <organization>AMAI CHARITABLE TRUST</organization>
  </responsible_party>
  <keyword>RENAL CALCULI HERBMED PLUS</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Calculi</mesh_term>
    <mesh_term>Kidney Calculi</mesh_term>
    <mesh_term>Nephrolithiasis</mesh_term>
  </condition_browse>
  <pending_results>
    <submitted>January 4, 2016</submitted>
    <returned>February 2, 2016</returned>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

